Newsletter - December 17, 2020
The Gifts of the Pandemic: Looking for the Silver Lining? Yes, There is One.
As the year of the worst pandemic in modern times comes to an end, it is time to reflect on five major changes in drug development and healthcare, that are here to stay for good. To be fair these are less of changes and more of appreciation of what existed before but was used less efficiently....Read More
The Penalties of the Pandemic: Pain Points That Intend to Stay
It seems like stating the obvious, but the pandemic will have some long-term negative effects on the FDA-regulated industry at least for the next few years which would tangibly and perceptively affect new product development and healthcare. Here we list five that seem most obvious to us. First, there is a huge backlog of clinical trials.....Read More
The Gifts of the Pandemic: Looking for the Silver Lining? Yes, There is One.
As the year of the worst pandemic in modern times comes to an end, it is time to reflect on five major changes in drug development and healthcare, that are here to stay for good. To be fair these are less of changes and more of appreciation of what existed before but was used less efficiently....Read More
The Penalties of the Pandemic: Pain Points That Intend to Stay
It seems like stating the obvious, but the pandemic will have some long-term negative effects on the FDA-regulated industry at least for the next few years which would tangibly and perceptively affect new product development and healthcare. Here we list five that seem most obvious to us. First, there is a huge backlog of clinical trials.....Read More
